OGT 2115
OGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT 2115 has anti-angiogenic properties (IC50 of 1 μM) . OGT 2115 also inhibits heparan sulfate degradation activity[1][2].
Product Specifications
CAS Number
853929-59-6
UNSPSC
12352005
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ogt-2115.html
Purity
99.62
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
O=C(O)CC1=CC=C(OC(C2=CC=C(NC(/C=C/C3=CC=C(Br)C=C3)=O)C(F)=C2)=N4)C4=C1
Molecular Formula
C24H16BrFN2O4
Molecular Weight
495.30
References & Citations
[1][1]Courtney SM, et al. Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorg Med Chem Lett. 2005 May 2;15 (9) :2295-9.|[2]Li Y, et al. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase. Int J Mol Med. 2013 May;31 (5) :1234-42.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC221149L4V 200 µL
UTP15 (NM_032175) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
ARP85609_P050 100 µL
AFAP1 Antibody - middle region (ARP85609_P050)
Sign In for Pricing
View Details MBS6186200-01 0.1 mL
ZBTB16 (Zinc Finger and BTB Domain Containing 16, PLZF, ZNF145) (PE)
Sign In for Pricing
View Details MBS6186200-02 5x 0.1 mL
ZBTB16 (Zinc Finger and BTB Domain Containing 16, PLZF, ZNF145) (PE)
Sign In for Pricing
View Details 
K1549006 1.0 µg DNA
OR9Q1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details